title: Age at Death of Creutzfeldt-Jakob disease in subsequent family generation carrying the E200K mutation of the prion protein gene.
abstract: BACKGROUND
  The E200K mutation of the prion protein gene (PRNP) is the most frequent amino acid substitution in genetic Creutzfeldt-Jakob disease and is the only one responsible for the appearance of clustered cases in the world. In the Israel and Slovakian clusters, age of disease onset was reduced in successive generations but the absence of a clear molecular basis raised the possibility that this event was an observational bias. The aim of the present study was to investigate possible selection biases or confounding factors related to anticipation in E200K CJD patients belonging to a cluster in Southern Italy.
  
  
  METHODS
  Clinical and demographical data of 41 parent-offspring pairs from 19 pedigrees of the Italian cluster of E200K patients were collected. Age at death of parents was compared with age at death of E200K CJD offspring. Subgroup analyses were performed for controlling possible selection biases, confounding factors, or both.
  
  
  RESULTS
  The mean age at death/last follow-up of the parent generation was 71.4 years while that of CJD offspring was 59.3 years with an estimated anticipation of 12.1 years. When the same analysis was performed including only parents with CJD or carrying the E200K mutation (n = 26), the difference between offspring and parents increased to 14.8 years.
  
  
  CONCLUSIONS
  These results show that early age at death occurs in offspring of families carrying the E200K PRNP mutation and that this event is not linked to observational biases. Although molecular or environmental bases for this occurrence remain unsettled, this information is important for improving the accuracy of information to give to mutated carriers.
authors.affiliation: Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy. maurizio.pocchiari@iss.it
authors.forename: Maurizio
authors.initials: M
authors.lastname: Pocchiari
authors.forename: Anna
authors.initials: A
authors.lastname: Poleggi
authors.forename: Maria
authors.initials: M
authors.lastname: Puopolo
authors.forename: Marco
authors.initials: M
authors.lastname: D'Alessandro
authors.forename: Dorina
authors.initials: D
authors.lastname: Tiple
authors.forename: Anna
authors.initials: A
authors.lastname: Ladogana
mesh_terms: D000367:Age Factors; D000368:Aged; D007562:Creutzfeldt-Jakob Syndrome / Q000235:genetics* / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D000072002:Prion Proteins; D011328:Prions / Q000235:genetics*
chemical_list: C512656:PRNP protein, human; D000072002:Prion Proteins; D011328:Prions
references.citation: Transfusion. 2011 Jul;51(7):1556-66
references.pmid: 21214582
references.citation: Med Hypotheses. 2005;65(3):448-77
references.pmid: 15908137
references.citation: Am J Hum Genet. 1996 Nov;59(5):990-8
references.pmid: 8900225
references.citation: Genet Epidemiol. 2010 Nov;34(7):756-68
references.pmid: 20878717
references.citation: PLoS Pathog. 2011 Nov;7(11):e1002350
references.pmid: 22072968
references.citation: PLoS Pathog. 2010 Jul 01;6(7):e1000977
references.pmid: 20625387
references.citation: Nature. 2012 Aug 23;488(7412):471-5
references.pmid: 22914163
references.citation: Ann Intern Med. 2001 Jun 19;134(12):1124-9
references.pmid: 11412053
references.citation: Ann Hum Biol. 1990 Nov-Dec;17(6):543-6
references.pmid: 2281946
references.citation: Lancet. 1997 Aug 16;350(9076):459-60
references.pmid: 9274580
references.citation: Am J Hum Genet. 1996 Nov;59(5):973-9
references.pmid: 8900222
references.citation: Neurology. 2005 May 10;64(9):1592-7
references.pmid: 15883322
references.citation: BMC Med Genet. 2011 May 22;12:73
references.pmid: 21600043
references.citation: Brain. 2004 Oct;127(Pt 10):2348-59
references.pmid: 15361416
references.citation: Neurology. 1999 Oct 12;53(6):1328-9
references.pmid: 10522892
references.citation: Neurology. 2005 May 10;64(9):1628-31
references.pmid: 15883330
references.citation: Ann Eugen. 1948 Apr;14(2):125-32
references.pmid: 18863976
references.citation: Lancet. 1990 Sep 8;336(8715):637-8
references.pmid: 1975415
references.citation: Acta Virol. 2002;46(1):31-9
references.pmid: 12197632
references.citation: Cent Eur J Public Health. 2011 Sep;19(3):158-64
references.pmid: 22026293
references.citation: Hum Genet. 2005 Nov;118(2):166-74
references.pmid: 16187142
references.citation: BMC Med Genet. 2009 Dec 26;10:146
references.pmid: 20035629
references.citation: Lancet. 1990 Aug 25;336(8713):514-5
references.pmid: 1975028
references.citation: Neurol Res. 1998 Dec;20(8):684-8
references.pmid: 9864731
references.citation: Lancet. 1998 Dec 19-26;352(9145):1989-90
references.pmid: 9872257
references.citation: Mol Med. 1995 Sep;1(6):607-13
references.pmid: 8529127
references.citation: Emerg Infect Dis. 2012 Jun;18(6):901-7
references.pmid: 22607808
references.citation: Eur J Hum Genet. 2006 Mar;14(3):273-81
references.pmid: 16391566
references.citation: Neurobiol Dis. 2012 Mar;45(3):1010-7
references.pmid: 22198568